Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy
Anemia is a frequent, yet increasingly recognized, comorbidity in diabetes mellitus (DM), with prevalence often driven by multifactorial mechanisms. Hematinic deficiencies, common in this population, may arise from associated comorbidities or medications, such as metformin, as well as other drugs co...
Saved in:
| Main Authors: | Christina Antoniadou, Efstratios Gavriilidis, Konstantinos Ritis, Dimitrios Tsilingiris |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Metabolism Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936824000768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study the levels of Erythropoietin, Glutathione and Malondialdehyde in women with gestational anemia
by: Aaraf Sabah Abdulwaheed, et al.
Published: (2023-02-01) -
A comparison of Erythropoietin hormone level at male diabetic patients with and without nephropathy
by: Esraa Mahdi Zahid, et al.
Published: (2013-12-01) -
Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01) -
HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01) -
HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)